Wellnex Life Limited (ASX:WNX)
Australia · Delayed Price · Currency is AUD 0.0800
-0.0050 (-5.88%)
Mar 13, 2026, 11:20 AM AEST
Wellnex Life Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 24.58 | 23.63 | 16.83 | 27.86 | 18.61 | 1.2 |
Other Revenue | - | - | - | 0.03 | - | - |
| 24.58 | 23.63 | 16.83 | 27.89 | 18.61 | 1.2 | |
Revenue Growth (YoY) | 6.27% | 40.39% | -39.67% | 49.90% | 1457.07% | 27.94% |
Cost of Revenue | 16.28 | 16.75 | 11.86 | 23.14 | 14.45 | 1.36 |
Gross Profit | 8.3 | 6.88 | 4.97 | 4.75 | 4.16 | -0.17 |
Selling, General & Admin | 9.11 | 9.93 | 10.26 | 11.3 | 10.22 | 8.4 |
Operating Expenses | 14.82 | 15.49 | 11.53 | 11.85 | 10.37 | 8.52 |
Operating Income | -6.51 | -8.62 | -6.56 | -7.1 | -6.21 | -8.68 |
Interest Expense | -1.78 | -2.63 | -2.4 | -1.68 | -0.96 | -1.63 |
Other Non Operating Income (Expenses) | 1.06 | -0.5 | 0.11 | - | 0.19 | -0.36 |
EBT Excluding Unusual Items | -7.23 | -11.74 | -8.85 | -8.78 | -6.98 | -10.67 |
Merger & Restructuring Charges | -1.67 | -2.32 | -1.11 | - | - | - |
Impairment of Goodwill | - | - | - | - | -0.47 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -1.1 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -8.35 |
Asset Writedown | -1.11 | -1.48 | -4.45 | -5.07 | - | - |
Other Unusual Items | 0.14 | -0.06 | 0.66 | - | - | - |
Pretax Income | -9.87 | -15.6 | -13.74 | -13.85 | -7.45 | -20.12 |
Earnings From Continuing Operations | -9.87 | -15.6 | -13.74 | -13.85 | -7.45 | -20.12 |
Minority Interest in Earnings | - | - | - | - | - | -4.57 |
Net Income | -9.87 | -15.6 | -13.74 | -13.85 | -7.45 | -24.69 |
Net Income to Common | -9.87 | -15.6 | -13.74 | -13.85 | -7.45 | -24.69 |
Shares Outstanding (Basic) | 51 | 29 | 17 | 8 | 6 | 5 |
Shares Outstanding (Diluted) | 51 | 29 | 17 | 8 | 6 | 5 |
Shares Change (YoY) | 101.00% | 72.05% | 110.65% | 33.80% | 26.05% | 16.98% |
EPS (Basic) | -0.19 | -0.53 | -0.81 | -1.72 | -1.23 | -5.16 |
EPS (Diluted) | -0.19 | -0.53 | -0.81 | -1.72 | -1.24 | -5.16 |
Free Cash Flow | -2.7 | -1.96 | -6.82 | -6.19 | -8.61 | -5.17 |
Free Cash Flow Per Share | -0.05 | -0.07 | -0.40 | -0.77 | -1.43 | -1.08 |
Gross Margin | 33.78% | 29.12% | 29.53% | 17.04% | 22.36% | -13.81% |
Operating Margin | -26.50% | -36.47% | -38.97% | -25.45% | -33.36% | -726.69% |
Profit Margin | -40.16% | -66.05% | -81.64% | -49.64% | -40.03% | -2065.94% |
Free Cash Flow Margin | -11.00% | -8.28% | -40.52% | -22.19% | -46.28% | -432.38% |
EBITDA | -5.07 | -7.24 | -5.74 | -6.82 | -6.14 | -8.67 |
EBITDA Margin | -20.64% | -30.63% | -34.09% | -24.46% | -32.99% | - |
D&A For EBITDA | 1.44 | 1.38 | 0.82 | 0.27 | 0.07 | 0.01 |
EBIT | -6.51 | -8.62 | -6.56 | -7.1 | -6.21 | -8.68 |
EBIT Margin | -26.50% | -36.47% | -38.97% | -25.45% | -33.36% | - |
Revenue as Reported | - | - | - | 27.89 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.